ADTX

Aditxt Inc
1.55
0.11 (7.64%)

Aditxt Inc. (ADTX) Fundamentals

Aditxt Inc is a life sciences company which focuses on prolong life and enhance life quality of transplanted patients. The firm develop products designed to induce tolerance to transplanted organs. The firm's immunosuppressive (anti-rejection) drugs has made possible life-saving organ transplantation procedures as these drugs prevent or delay organ rejection. It is also developing a technology called Apoptotic DNA Immunotherapy (ADi) which utilizes tolerogenic approach that utilizes the body's natural process of cell death, to deliver a modified antigen that signals the immune system to become tolerant to transplanted tissues.
SHARE INFORMATION
Market Cap$ 6,185,712
Shares Outstanding4,295,633
Float4,244,015
Percent Float98.8%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 105,034
Latest Fiscal EPS$ -112.50
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions36
Institutional Holdings Date2023-01-31
Institutional Bought Previous 3 Months70,984
Institutional Holdings Percent7.1%
Institutional Sold Previous 3 Months45,226
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months-
Insider Holdings Percent29.9
Insider Sold Previous 3 Months-
Insider Shares Owned1,285,661
TRADING INFO
52 Week High$ 28.49
52 Week Low$ 1.00
52 Week High Change$ -93.25
21 Day Moving Average$ 1.4063
21 Day Extended Moving Average$ 1.4123
50 Day Moving Average$ 1.4769
50 Day Extended Moving Average$ 1.7236
200 Day Moving Average$ 6.746
200 Day Extended Moving Average$ 11.2543
10 Day Average Volume152,308
20 Day Average Volume179,876
30 Day Average Volume236,964
50 Day Average Volume171,979
Alpha-0.136844
Beta1.6017
Standard Deviation0.260318
R20.115242
7 Day Price Change$ -0.02
7 Day Percent Change-1.37%
21 Day Price Change$ 0.06
21 Day Percent Change4.35%
30 Day Price Change$ 0.2854
30 Day Percent Change24.72%
Month to Date Price Change$ 0.08
Month to Date Percent Change5.88%
Quarter to Date Price Change$ 0.2854
Quarter to Date Percent Change24.72%
180 Day Price Change$ -6.20
180 Day Percent Change-81.14%
200 Day Price Change$ -7.24
200 Day Percent Change-83.4%
Year to Date Price Change$ 0.2854
Year to Date Percent Change24.72%

Aditxt Inc. (ADTX) Key Ratios

PROFITABILITY
EBIT Margin-4,832.1%
EBITDA Margin-4,772.7%
Pre-Tax Profit Margin0.0%
Profit Margin Count0.0%
Gross Margin20.9%
Profit Margin TOT0.0%
INCOME STATEMENTS
Revenue$ 748,119
Revenue Per Share$ 0.1742
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book0.50
Total Debt To Equity0.30
Int Coverage-18.00
Current Ratio2.90
Leverage Ratio2.20
Quick Ratio2.40
Long Term Debt To Capital0.14
VALUATION MEASURES
PE Ratio0.00
Enterprise Value$ 245,051
Price to Sales8.2684
Price to Free Cash-0.40
PE High Last 5 Years0.00
Price To Book0.50
Price To Cash Flow0.00
PE Low Last 5 Years0.00
Price to Tangible Book0.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover0.20
Invoice Turnover0.70
Assets Turnover0.00
Return Assets-224.52
Return on Equity-339.11
Return on Capital-242.40

Aditxt Inc. (ADTX) Profile

PROFILE INFO
Issue TypeCS
SEC Type-
AuditorDBBMcKennon
CEOAmro A. Albanna
Emplyoees58
Last AuditUE
CIK0001726711
IndustryBiotechnology
SectorHealthcare
NAICSMedicinal and Botanical Manufacturing(325411)
CONTACT INFO
Address737 North Fifth Street
Suite 200
Richmond, VA 23219
Websitehttps://www.aditxt.com
Facsimile-
Telephone+1 650 870-1200
Email-


Your Recent History
NASDAQ
ADTX
Aditxt
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.